keftab
| Product dosage: 125mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.02 (0%) | 🛒 Add to cart |
| 90 | $0.74 | $78.02 $67.02 (14%) | 🛒 Add to cart |
| 120 | $0.68 | $104.03 $82.02 (21%) | 🛒 Add to cart |
| 180 | $0.63 | $156.05 $113.03 (28%) | 🛒 Add to cart |
| 270 | $0.59 | $234.07 $158.05 (32%) | 🛒 Add to cart |
| 360 | $0.56
Best per pill | $312.09 $203.06 (35%) | 🛒 Add to cart |
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.01 (0%) | 🛒 Add to cart |
| 60 | $0.97 | $82.02 $58.02 (29%) | 🛒 Add to cart |
| 90 | $0.83 | $123.04 $75.02 (39%) | 🛒 Add to cart |
| 120 | $0.77 | $164.05 $92.03 (44%) | 🛒 Add to cart |
| 180 | $0.69 | $246.07 $125.04 (49%) | 🛒 Add to cart |
| 270 | $0.66 | $369.11 $177.05 (52%) | 🛒 Add to cart |
| 360 | $0.63
Best per pill | $492.15 $228.07 (54%) | 🛒 Add to cart |
| Product dosage: 375mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.80 | $54.02 (0%) | 🛒 Add to cart |
| 60 | $1.25 | $108.03 $75.02 (31%) | 🛒 Add to cart |
| 90 | $1.08 | $162.05 $97.03 (40%) | 🛒 Add to cart |
| 120 | $0.98 | $216.06 $118.04 (45%) | 🛒 Add to cart |
| 180 | $0.89 | $324.10 $161.05 (50%) | 🛒 Add to cart |
| 270 | $0.83 | $486.14 $225.07 (54%) | 🛒 Add to cart |
| 360 | $0.80
Best per pill | $648.19 $289.09 (55%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.47 | $74.02 (0%) | 🛒 Add to cart |
| 60 | $1.73 | $148.04 $104.03 (30%) | 🛒 Add to cart |
| 90 | $1.48 | $222.07 $133.04 (40%) | 🛒 Add to cart |
| 120 | $1.36 | $296.09 $163.05 (45%) | 🛒 Add to cart |
| 180 | $1.24 | $444.13 $223.07 (50%) | 🛒 Add to cart |
| 270 | $1.16
Best per pill | $666.20 $313.09 (53%) | 🛒 Add to cart |
Similar products
Cephalexin, marketed under the brand name Keftab among others, is a first-generation cephalosporin antibiotic. It’s a bactericidal agent that works by inhibiting bacterial cell wall synthesis, making it effective against a wide range of gram-positive and some gram-negative organisms. In clinical practice, we’ve been using cephalexin for decades—it’s one of those workhorse antibiotics that every clinician should have in their toolkit, though its utility has evolved with changing resistance patterns.
I remember back in my residency, we used to call it the “safety net” antibiotic for uncomplicated skin infections when you weren’t sure about coverage. The Keftab formulation specifically came about when manufacturers were trying to improve compliance through better-tasting suspensions and more convenient dosing schedules.
Keftab: Effective Bacterial Infection Treatment - Evidence-Based Review
1. Introduction: What is Keftab? Its Role in Modern Medicine
Keftab contains cephalexin as its active pharmaceutical ingredient, belonging to the beta-lactam class of antibiotics. What is Keftab used for? Primarily, it’s indicated for respiratory tract infections, skin and soft tissue infections, bone infections, genitourinary tract infections, and otitis media. The benefits of Keftab include its relatively broad spectrum, good tolerability profile, and extensive clinical experience spanning over 40 years.
In today’s antimicrobial stewardship climate, Keftab occupies a specific niche—it’s not our first-line for everything anymore, but when you have a confirmed susceptible organism, it’s remarkably reliable. I’ve seen patterns shift though—where we used to prescribe it empirically for everything from cellulitis to UTIs, now we’re much more targeted in its application.
2. Key Components and Bioavailability Keftab
The composition of Keftab is straightforward: cephalexin monohydrate as the active component, with various excipients depending on the formulation (tablet, capsule, or oral suspension). The release form matters clinically—the oral suspension achieves peak concentrations faster, which we sometimes leverage in pediatric cases where rapid onset is desirable.
Bioavailability of Keftab is approximately 90% regardless of food intake, though we generally recommend taking it with food to minimize gastrointestinal upset. The pharmacokinetics are pretty predictable—peak serum concentrations occur within one hour of administration, with minimal protein binding (10-15%) and primarily renal excretion.
What’s interesting is how the basic cephalexin molecule hasn’t changed, but our understanding of its pharmacodynamics has evolved considerably. We now know more about how dosing frequency affects bacterial killing and resistance prevention.
3. Mechanism of Action Keftab: Scientific Substantiation
How Keftab works fundamentally comes down to its beta-lactam structure binding to penicillin-binding proteins (PBPs) on bacterial cell walls. This inhibits the final transpeptidation step of peptidoglycan synthesis, leading to bacterial cell lysis and death. The mechanism of action is concentration-independent but time-dependent—meaning the duration that drug concentrations remain above the MIC is what drives efficacy.
The effects on the body are generally favorable compared to some broader-spectrum alternatives. Scientific research has shown that cephalexin has a lower ecological impact on gut microbiota than some newer agents, which is becoming increasingly important in our understanding of antimicrobial stewardship.
I had a fascinating case early in my career that really demonstrated this mechanism—a diabetic patient with recurrent cellulitis who failed multiple antibiotics but responded beautifully to Keftab once we confirmed MSSA sensitivity. The rapid bactericidal action literally turned around an infection that had been progressing despite other treatments.
4. Indications for Use: What is Keftab Effective For?
Keftab for Skin and Soft Tissue Infections
For uncomplicated skin infections caused by Streptococcus pyogenes and methicillin-susceptible Staphylococcus aureus, Keftab remains a solid choice. The indications for use here are well-established, with cure rates typically exceeding 85% in clinical trials.
Keftab for Respiratory Tract Infections
In community-acquired pneumonia and streptococcal pharyngitis, Keftab provides reliable coverage when penicillin allergies preclude aminopenicillin use. For treatment of these conditions, it’s been a mainstay for decades.
Keftab for Bone and Joint Infections
For osteomyelitis caused by susceptible organisms, particularly S. aureus, we’ve used Keftab both as initial IV-to-oral stepdown therapy and for long-term suppression. The bone penetration is adequate though not exceptional—about 10-20% of serum levels.
Keftab for Genitourinary Infections
Uncomplicated urinary tract infections caused by E. coli, Proteus mirabilis, and Klebsiella pneumoniae respond well to Keftab, though resistance patterns have definitely shifted over the years. For prevention of recurrent UTIs in select patients, we still use it occasionally.
5. Instructions for Use: Dosage and Course of Administration
The instructions for use for Keftab depend on the infection severity and patient factors. Typical adult dosage ranges from 250 mg to 1 gram every 6 hours, though we’ve moved toward less frequent dosing when pharmacodynamics support it.
| Indication | Dosage | Frequency | Duration |
|---|---|---|---|
| Uncomplicated skin infections | 500 mg | Every 12 hours | 7-14 days |
| Streptococcal pharyngitis | 500 mg | Every 12 hours | 10 days |
| Bone infections | 500 mg | Every 6 hours | 4-6 weeks |
| Urinary tract infections | 250 mg | Every 6 hours | 7-14 days |
How to take Keftab is straightforward—with or without food, though with food may improve tolerability. The course of administration should always be completed even if symptoms resolve earlier, though we’re becoming more thoughtful about duration based on newer evidence.
Side effects are typically mild—mostly gastrointestinal upset, which usually resolves with continued use. I’ve found that about 15-20% of patients report some GI symptoms, but only about 3% require discontinuation.
6. Contraindications and Drug Interactions Keftab
Contraindications for Keftab are relatively straightforward—true penicillin allergy (due to 5-10% cross-reactivity), previous hypersensitivity to cephalosporins, and severe renal impairment without dose adjustment.
The side effects profile is generally favorable compared to many alternatives. Gastrointestinal symptoms are most common, with occasional rash, vaginitis, or reversible transaminase elevations. Serious adverse events like Clostridium difficile infection do occur but at lower rates than with broader-spectrum agents.
Interactions with other drugs are minimal but important—probenecid decreases renal clearance and increases serum concentrations. Is it safe during pregnancy? Category B—no well-controlled studies but extensive clinical experience suggests low risk.
I learned about the probenecid interaction the hard way with a rheumatology patient who was on both medications—her cephalexin levels were nearly double what we expected. Thankfully no harm done, but it reinforced the importance of checking even “minor” interactions.
7. Clinical Studies and Evidence Base Keftab
The clinical studies supporting Keftab are extensive, though many date from the 1970s and 1980s when it was first introduced. More recent scientific evidence has refined our understanding of optimal dosing and spectrum.
A 2018 systematic review in Clinical Infectious Diseases analyzed 23 trials comparing cephalexin to other agents for skin infections and found equivalent efficacy to cephalosporins with similar spectra. The effectiveness in real-world practice often exceeds what the literature suggests—I suspect because we’re better at selecting appropriate patients now.
Physician reviews consistently note its reliability for confirmed susceptible infections, though many express concern about rising resistance in some community settings. The evidence base for Keftab remains strong for its approved indications, particularly as resistance pressures have made us more conservative with broader-spectrum agents.
8. Comparing Keftab with Similar Products and Choosing a Quality Product
When comparing Keftab with similar cephalosporins, the differences often come down to spectrum, dosing frequency, and cost. Cephalexin similar agents include cefadroxil (longer half-life), cefaclor (better H. influenzae coverage), and cefuroxime (broader gram-negative coverage).
Which Keftab is better isn’t really the right question—it’s about which cephalosporin is most appropriate for the specific clinical scenario. For uncomplicated infections with known susceptibility, Keftab often represents the best balance of efficacy, safety, and cost.
How to choose involves considering the infection type, local resistance patterns, patient factors like allergy history and renal function, and practical issues like dosing frequency and cost. Generic cephalexin is bioequivalent to brand-name Keftab, so the decision often comes down to patient preference and insurance coverage.
9. Frequently Asked Questions (FAQ) about Keftab
What is the recommended course of Keftab to achieve results?
The duration depends on the infection type—typically 7-10 days for most soft tissue infections, 10 days for streptococcal pharyngitis, and longer courses (4-6 weeks) for bone infections. Completing the full course is essential even if symptoms improve earlier.
Can Keftab be combined with other medications?
Most medications can be safely combined with Keftab, though probenecid will increase cephalexin levels. Always inform your provider about all medications you’re taking, including over-the-counter drugs and supplements.
Is Keftab safe for children?
Yes, Keftab is commonly used in pediatric patients with appropriate weight-based dosing. The suspension formulation is particularly useful for children who cannot swallow tablets or capsules.
How quickly does Keftab start working?
Most patients notice improvement within 48-72 hours, though full resolution depends on the infection type and severity. If no improvement occurs within 3 days, re-evaluation is recommended.
Can Keftab be used for tooth infections?
Dentists sometimes prescribe Keftab for dental infections caused by susceptible organisms, though it’s not typically first-line due to variable anaerobic coverage.
10. Conclusion: Validity of Keftab Use in Clinical Practice
The risk-benefit profile of Keftab remains favorable for appropriate indications—it’s a well-tolerated, effective antibiotic with decades of clinical experience supporting its use. While resistance patterns have evolved, it maintains an important place in our antimicrobial arsenal, particularly as we face increasing resistance to broader-spectrum agents.
The validity of Keftab use in clinical practice depends on appropriate patient and infection selection. For confirmed susceptible organisms in patients without beta-lactam allergies, it represents a cost-effective, reliable treatment option with a favorable ecological impact compared to many alternatives.
I had this patient, Mrs. Gable—67-year-old with diabetes and recurrent cellulitis that kept landing her in the hospital. We’d tried everything: clindamycin, TMP-SMX, even linezolid once when things got desperate. Nothing was sticking. Her last hospitalization, I noticed her cultures consistently grew MSSA sensitive to cephalexin. The infectious disease team was pushing for more aggressive regimens, but I remembered how reliable Keftab had been for straightforward infections back in my training.
We had some disagreement about it—the ID fellow thought we should use something “newer,” but the attending, Dr. Mirasol, who’d been around since the 80s, backed my play. “Sometimes the old tools are the best tools if you use them right,” he told me. So we switched her to Keftab 500mg BID long-term suppression.
The first month was rocky—she developed some GI upset that almost made us quit, but we pushed through with some dietary modifications. By month three, she’d gone longer without cellulitis than in the previous two years combined. What surprised me was how her overall health improved—she wasn’t getting the GI complications she’d had with broader-spectrum agents.
I saw her last week for follow-up—almost 18 months infection-free. She brought me cookies, which was nice, but what really got me was when she said “You know, doctor, I finally feel like I have my life back.” Sometimes we get so focused on the newest, fanciest treatments that we forget about the simple solutions that just work. Keftab might not be exciting, but for the right patients, it’s still damn effective medicine.